These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21624656)

  • 21. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resolution of recurrent conjunctival papilloma after topical and intralesional interferon alpha2b with partial excision in a child.
    Kothari M; Mody K; Chatterjee D
    J AAPOS; 2009 Oct; 13(5):523-5. PubMed ID: 19840738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical Interferon Alpha-2b Induced Reactive Lymphoid Hyperplasia Masquerading as Orbital Extension of Ocular Surface Squamous Neoplasia.
    Lee GA; Hess L; Glasson WJ; Whitehead K
    Cornea; 2018 Jun; 37(6):796-798. PubMed ID: 29489517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia.
    Huerva V; Sánchez MC; Mangues I
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):143-5. PubMed ID: 17444802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Topical interferon alfa-2b for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
    Pérez de Arcelus M; Aranguren M; Andonegui J
    An Sist Sanit Navar; 2012; 35(1):137-41. PubMed ID: 22552136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent carcinoma in situ of the conjunctiva and cornea (Bowen's disease).
    Sanders N; Bedotto C
    Am J Ophthalmol; 1972 Oct; 74(4):688-93. PubMed ID: 5075137
    [No Abstract]   [Full Text] [Related]  

  • 28. Intralesional and topical interferon therapy following incomplete primary excision of ocular surface squamous neoplasia.
    Rishi P; Shields CL
    Indian J Ophthalmol; 2016 Jun; 64(6):460-1. PubMed ID: 27488156
    [No Abstract]   [Full Text] [Related]  

  • 29. [Amniotic membrane for ocular surface reconstruction after conjunctival squamous cell carcinoma resection].
    Carvalho-Rêgo PR; Gomes JA; Ballalai PL; Cunha MC; Sousa LB; Erwenne CM
    Arq Bras Oftalmol; 2008; 71(1):22-7. PubMed ID: 18408832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
    Rahimi F; Alipour F; Ghazizadeh Hashemi H; Hashemian MN; Mehrdad R
    Arch Iran Med; 2009 Jan; 12(1):55-9. PubMed ID: 19111031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical alpha-interferon in recurrent conjunctival papilloma.
    de Keizer RJ; de Wolff-Rouendaal D
    Acta Ophthalmol Scand; 2003 Apr; 81(2):193-6. PubMed ID: 12752062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refractory squamous cell carcinoma of the conjunctiva treated with subconjunctival ranibizumab (Lucentis): a two-year study.
    Finger PT; Chin KJ
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):85-9. PubMed ID: 22186988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetrating keratoplasty for treatment of recurrent squamous cell carcinoma of the cornea in a horse.
    van der Woerdt A; Gilger BC; Wilkie DA
    J Am Vet Med Assoc; 1996 May; 208(10):1692-4. PubMed ID: 8641952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superficial keratectomy and topical mitomycin C as therapy for a corneal squamous cell carcinoma in a dog.
    Karasawa K; Matsuda H; Tanaka A
    J Small Anim Pract; 2008 Apr; 49(4):208-10. PubMed ID: 17725585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Apr; 110(4):625-6; author reply 626. PubMed ID: 12689863
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia.
    Rudkin AK; Muecke JS
    Br J Ophthalmol; 2011 Jul; 95(7):947-50. PubMed ID: 21252085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amniotic Membrane Grafting for Ocular Surface Inflammation Following Topical Interferon Alpha 2b Therapy.
    Shah SG; Mishra DK; Shah GY
    J Interferon Cytokine Res; 2022 Mar; 42(3):137-139. PubMed ID: 35298286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.
    Shields CL; Kaliki S; Kim HJ; Al-Dahmash S; Shah SU; Lally SE; Shields JA
    Cornea; 2013 Mar; 32(3):248-56. PubMed ID: 22580436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.